ONO Pharmaceutical Co., Ltd.
Ono Pharmaceutical is a Japanese prescription-drug company engaged in discovery, clinical development and commercialization of therapies for serious diseases. Its research and development strategy uses small molecules, biologics and selected externally partnered technologies to address oncology, immune conditions and other specialty therapeutic needs. The company also collaborates with academic institutions and biotechnology developers to expand its drug discovery capabilities. Ono is headquartered in Japan and trades on the Tokyo Stock Exchange under ticker 4528.
Company at a glance
Corporate information
- Company entity
- ONO Pharmaceutical Co., Ltd.
- Headquarters / principal office
- Japan
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.ono-pharma.com/en
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
TSE: 4528
small molecules · biologics · oligonucleotide partnerships
oncology · immunology · neurology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Ono Pharmaceutical is a Japanese prescription-drug company engaged in discovery, clinical development and commercialization of therapies for serious diseases. Its research and development strategy uses small molecules, biologics and selected externally partnered technologies to address oncology, immune conditions and other specialty therapeutic needs. The company also collaborates with academic institutions and biotechnology developers to expand its drug discovery capabilities. Ono is headquartered in Japan and trades on the Tokyo Stock Exchange under ticker 4528.
Business, technology & evidence
- SecuritiesTSE: 4528
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · ONO Pharmaceutical Co., Ltd. ↗ONO Pharmaceutical Co., Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.